Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-07

FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for finasteride filed by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)

Snippet

SUPPL AP for FINASTERIDE (FINASTERIDE)